Jeremy L. Stigall - 13 May 2022 Form 3 Insider Report for ClearPoint Neuro, Inc. (CLPT)

Role
GM, Biologics & Drug Delivery
Signature
/s/ Richard F. Mattern by Power of Attorney for Jeremy L. Stigall
Issuer symbol
CLPT
Transactions as of
13 May 2022
Net transactions value
$0
Form type
3
Filing time
19 May 2022, 21:59:40 UTC
Next filing
14 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CLPT Common Stock $25,683 13 May 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CLPT Stock Option (Right to Buy) 13 May 2022 Common Stock 5,875 $16.71 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 22,563 shares of restricted stock, 19,274 shares of which are unvested as of the date of this filing.
F2 The option agreement provides that the option becomes exercisable twenty percent (20%) on the first anniversary of the option's grant date with the remaining eighty percent (80%) becoming exercisable in two equal annual installments on the second and third anniversaries, respectively, of the option's grant date. The option was granted on August 20, 2021.

Remarks:

Power of Attorney is attached to this Form 3 as Exhibit 24.